A randomised controlled trial of brief physiotherapy informed by Acceptance and Commitment Therapy for chronic low back pain: the PACT study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN95392287

Enrollment

240

Registered

2014-10-22

Start date

2014-11-01

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Musculoskeletal disorders

Interventions

PACT: a brief physiotherapy intervention based on ACT principles optimised to promote self-management, consisting of two 60 minute face-to-face sessions one week apart, of assessment, individualised t

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged over 18 years 2. Back pain including associated leg pain of greater than 12 weeks duration 3. Scoring 3 points or more on the Roland-Morris Disability Questionnaire (RMDQ) 4. Able and willing to give informed consent and attend treatment 5. Adequate understanding of spoken and written English to complete trial data collection and participate in programme

Exclusion criteria

Exclusion criteria: 1. Medically diagnosed lumbar spine pathology (e.g. inflammatory arthritis, fracture, cancer). 2. Deteriorating neurological signs (stable neurological signs and pain of apparently neuropathic origin are not exclusion criteria). 3. Previous or awaiting spinal surgery. 4. Psychiatric illness (e.g. extremely distressed/severe depression, personality disorders, posttraumatic stress disorders). 5. Drug or alcohol misuse. 6. Prior multidisciplinary or CBT pain management at any time. 7. Other physiotherapy in previous 6 months.

Design outcomes

Primary

Measure	Time frame
Self-report of disability due to low back pain, assessed using the Roland-Morris Disability Questionnaire (RMDQ; Roland and Morris, 1983) at baseline, 3 months and 12 months	—

Secondary

Measure	Time frame
Measured at baseline, 3 months and 12 months: 1. Quality of life, measured using the Work and Social Adjustment Scale and EQ-5D-5L 2. Pain, measured using the visual analogue scale 3. Function, measured using Patient Specific Functional Scale 4. Mood, measures using Generalised Anxiety Disorder-7 and Patient Health Questionnaire-9 5. Acceptance, measures using Chronic Pain Acceptance Questionnaire-8 6. Committed action, measured using Committed Action Questionnaire-8 7. Pain self efficacy, measured using pain self-efficacy questionnaire 8. Satisfaction, measured using Satisfaction with Life, Global Improvement and Treatment Credibility scales 9. Health economics, measured using EQ-5D-5L and SF-6D	—

Measure

Time frame

Measured at baseline, 3 months and 12 months: 1. Quality of life, measured using the Work and Social Adjustment Scale and EQ-5D-5L 2. Pain, measured using the visual analogue scale 3. Function, measured using Patient Specific Functional Scale 4. Mood, measures using Generalised Anxiety Disorder-7 and Patient Health Questionnaire-9 5. Acceptance, measures using Chronic Pain Acceptance Questionnaire-8 6. Committed action, measured using Committed Action Questionnaire-8 7. Pain self efficacy, measured using pain self-efficacy questionnaire 8. Satisfaction, measured using Satisfaction with Life, Global Improvement and Treatment Credibility scales 9. Health economics, measured using EQ-5D-5L and SF-6D

—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 1, 2026